Nukkleus Total Current Assets vs Accounts Payable Analysis

NUKK Stock  USD 1.52  0.01  0.65%   
Nukkleus financial indicator trend analysis is infinitely more than just investigating Nukkleus recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nukkleus is a good investment. Please check the relationship between Nukkleus Total Current Assets and its Accounts Payable accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nukkleus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.

Total Current Assets vs Accounts Payable

Total Current Assets vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nukkleus Total Current Assets account and Accounts Payable. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Nukkleus' Total Current Assets and Accounts Payable is 0.82. Overlapping area represents the amount of variation of Total Current Assets that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Nukkleus, assuming nothing else is changed. The correlation between historical values of Nukkleus' Total Current Assets and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Assets of Nukkleus are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Total Current Assets i.e., Nukkleus' Total Current Assets and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.82
Relationship DirectionPositive 
Relationship StrengthStrong

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Accounts Payable

An accounting item on the balance sheet that represents Nukkleus obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Nukkleus are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Nukkleus' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nukkleus current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nukkleus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.Selling General Administrative is expected to rise to about 3.4 M this year, although the value of Sales General And Administrative To Revenue will most likely fall to 0.19.
 2021 2022 2023 2024 (projected)
Total Operating Expenses28.3M3.2M3.7M3.5M
Cost Of Revenue22.2M16.3M18.7M14.8M

Nukkleus fundamental ratios Correlations

0.890.950.98-0.36-0.910.980.940.91-0.280.860.950.90.010.750.050.39-0.080.880.920.99-0.920.930.84
0.890.940.82-0.39-0.80.830.830.82-0.630.920.930.92-0.150.640.060.6-0.010.910.790.83-0.860.780.73
0.950.940.88-0.47-0.920.890.890.88-0.410.811.00.970.020.730.040.51-0.080.950.860.89-0.960.860.84
0.980.820.88-0.3-0.870.990.930.89-0.20.840.870.82-0.020.730.00.31-0.130.790.911.0-0.860.920.8
-0.36-0.39-0.47-0.30.59-0.36-0.4-0.410.41-0.36-0.43-0.30.52-0.670.420.120.46-0.3-0.51-0.30.52-0.38-0.61
-0.91-0.8-0.92-0.870.59-0.87-0.85-0.840.28-0.76-0.92-0.820.07-0.9-0.03-0.150.1-0.8-0.94-0.870.94-0.89-0.96
0.980.830.890.99-0.36-0.870.920.88-0.220.840.870.82-0.050.74-0.040.32-0.170.790.910.99-0.860.920.81
0.940.830.890.93-0.4-0.850.920.97-0.20.810.880.830.070.680.020.35-0.10.790.830.93-0.890.870.78
0.910.820.880.89-0.41-0.840.880.97-0.160.790.870.790.120.630.020.31-0.110.750.780.9-0.920.850.76
-0.28-0.63-0.41-0.20.410.28-0.22-0.2-0.16-0.61-0.39-0.40.68-0.360.18-0.420.09-0.42-0.33-0.20.28-0.2-0.29
0.860.920.810.84-0.36-0.760.840.810.79-0.610.80.74-0.350.70.030.340.00.720.830.85-0.740.770.71
0.950.931.00.87-0.43-0.920.870.880.87-0.390.80.970.060.720.140.50.010.960.860.88-0.960.860.84
0.90.920.970.82-0.3-0.820.820.830.79-0.40.740.970.130.60.20.650.081.00.770.82-0.890.790.74
0.01-0.150.02-0.020.520.07-0.050.070.120.68-0.350.060.13-0.380.420.230.310.12-0.230.0-0.090.0-0.15
0.750.640.730.73-0.67-0.90.740.680.63-0.360.70.720.6-0.38-0.02-0.14-0.120.590.940.73-0.710.740.9
0.050.060.040.00.42-0.03-0.040.020.020.180.030.140.20.42-0.020.00.980.20.030.010.01-0.03-0.01
0.390.60.510.310.12-0.150.320.350.31-0.420.340.50.650.23-0.140.0-0.010.660.090.32-0.390.270.07
-0.08-0.01-0.08-0.130.460.1-0.17-0.1-0.110.090.00.010.080.31-0.120.98-0.010.09-0.09-0.120.14-0.13-0.12
0.880.910.950.79-0.3-0.80.790.790.75-0.420.720.961.00.120.590.20.660.090.750.8-0.870.770.72
0.920.790.860.91-0.51-0.940.910.830.78-0.330.830.860.77-0.230.940.030.09-0.090.750.91-0.830.880.91
0.990.830.891.0-0.3-0.870.990.930.9-0.20.850.880.820.00.730.010.32-0.120.80.91-0.860.920.8
-0.92-0.86-0.96-0.860.520.94-0.86-0.89-0.920.28-0.74-0.96-0.89-0.09-0.710.01-0.390.14-0.87-0.83-0.86-0.88-0.87
0.930.780.860.92-0.38-0.890.920.870.85-0.20.770.860.790.00.74-0.030.27-0.130.770.880.92-0.880.92
0.840.730.840.8-0.61-0.960.810.780.76-0.290.710.840.74-0.150.9-0.010.07-0.120.720.910.8-0.870.92
Click cells to compare fundamentals

Nukkleus Account Relationship Matchups

Nukkleus fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets203.0K3.8M16.7M18.4M21.1M22.2M
Other Current Liab5.0M4.6M2.5M7.2M8.3M8.7M
Total Current Liabilities1.3M5.2M4.6M7.5M8.6M9.0M
Total Stockholder Equity(1.3M)(1.4M)12.0M10.9M12.5M13.2M
Net Debt158.3K161.0K1.3M(364.0K)(418.6K)(397.7K)
Retained Earnings(1.5M)(1.6M)(2.5M)(14.3M)(12.9M)(12.3M)
Cash23.5K82.8K355.7K364.0K418.6K439.6K
Cash And Short Term Investments192.5K82.9K355.7K364.0K418.6K439.6K
Common Stock Shares Outstanding6.3M257.8M367.2M10.1M9.1M8.6M
Liabilities And Stockholders Equity203.0K3.8M16.7M18.4M21.1M22.2M
Total Liab1.5M5.2M4.6M7.5M8.6M9.0M
Total Current Assets203.0K3.8M3.0M3.7M4.2M4.5M
Net Tangible Assets(1.3M)(1.4M)(1.6M)2.8M3.2M3.4M
Net Receivables3.7M2.7M35K966.1K1.1M1.0M
Short Term Investments168.9K12.01.2M248.2K285.4K224.1K
Non Current Liabilities Total246.2K247.6K180.5K254.9K229.4K285.1K
Inventory(172.8K)(3.7M)(2.6M)2.0M1.8M1.9M
Other Current Assets3.7M2.6M3.3M3.3M3.8M4.0M
Short Term Debt181.8K243.8K49.0K3.7M4.2M4.4M
Short Long Term Debt Total181.8K243.8K1.6M3.7M4.2M4.4M
Net Invested Capital(1.3M)(1.4M)12.0M10.9M12.5M13.2M
Net Working Capital(1.0M)(1.4M)(1.6M)(3.8M)(3.4M)(3.2M)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nukkleus is a strong investment it is important to analyze Nukkleus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nukkleus' future performance. For an informed investment choice regarding Nukkleus Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nukkleus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. If investors know Nukkleus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nukkleus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(19.36)
Revenue Per Share
7.024
Quarterly Revenue Growth
(0.97)
Return On Assets
(1.15)
Return On Equity
(7.42)
The market value of Nukkleus is measured differently than its book value, which is the value of Nukkleus that is recorded on the company's balance sheet. Investors also form their own opinion of Nukkleus' value that differs from its market value or its book value, called intrinsic value, which is Nukkleus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nukkleus' market value can be influenced by many factors that don't directly affect Nukkleus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nukkleus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nukkleus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nukkleus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.